Provided by Tiger Fintech (Singapore) Pte. Ltd.

PHARMARON

24.140
+0.3001.26%
Volume:5.03M
Turnover:120.92M
Market Cap:42.75B
PE:21.76
High:24.360
Open:24.200
Low:23.700
Close:23.840
52wk High:30.120
52wk Low:10.323
Shares:1.77B
HK Float Shares:294.27M
Volume Ratio:1.25
T/O Rate:1.71%
Dividend:0.22
Dividend Rate:0.91%
EPS(LYR):1.109
ROE:9.66%
ROA:4.91%
PB:2.67
PE(LYR):21.76
PS:2.88

Loading ...

HK Stock Connect Shareholding Changes | Nov 13

Stock News
·
Yesterday

HK Stock Connect Shareholding Changes | November 12

Stock News
·
Nov 12

HK Stock Connect Shareholding Changes | Nov 11

Stock News
·
Nov 11

Norges Bank Increases Stake in PHARMARON (03759) by 518,200 Shares at HK$25.76 per Share

Stock News
·
Nov 05

Pharmaron Beijing Co., Ltd. (03759) Announces October 2025 Share Capital and Movements Update

Bulletin Express
·
Nov 05

PHARMARON (03759) Shareholder Lou Xiaoqiang Pledges 2.154 Million Company Shares

Stock News
·
Nov 03

Goldman Sachs Raises PHARMARON (03759) Target Price to HK$30, Q3 Revenue Slightly Beats Expectations

Stock News
·
Nov 03

November 2025 Hong Kong Stock Market Investment Strategy and Top 10 Stock Picks

Stock News
·
Nov 02

CLSA Raises Pharmaron (03759) Target Price to HK$28.8, Maintains "Outperform" Rating

Stock News
·
Oct 31

HK Movers|Biotech Shares Soar. 3SBIO up 11%; RemeGen up 8%; SKB BIO up 7%; Junshi Bio up 5%; Hengrui Pharma and Innocare up 4%.

Tiger Newspress
·
Oct 31

UBS: Pharmaron (03759) Sees Accelerated New Order Growth in First Three Quarters, Raises Target Price to HK$32.9, Maintains "Buy" Rating

Stock News
·
Oct 30

Pharmaron Beijing Co., Ltd.: Nomination Committee Terms of Reference Announced

Bulletin Express
·
Oct 28

Pharmaron Beijing Co., Ltd. Announces Remuneration and Appraisal Committee Terms of Reference

Bulletin Express
·
Oct 28

Pharmaron Beijing Updates Audit Committee Terms of Reference

Bulletin Express
·
Oct 28

PHARMARON (03759) Nominates Professor Zeng Jinfeng as Candidate for Independent Non-Executive Director

Stock News
·
Oct 28

Pharmaron Beijing (3759) Reports Independent Director Resignation, By-Election Plan, and Proposed Articles Amendments

Bulletin Express
·
Oct 28

Pharmaron (3759) Releases 2025 Third Quarterly Results, Reports Solid Growth in Revenue

Bulletin Express
·
Oct 28

Pharmaron Beijing (3759) Announces Acquisition of 82.54% Stake in Biortus

Bulletin Express
·
Oct 28

PHARMARON (03759) Reports Q1-Q3 Results: Net Profit Attributable to Shareholders Drops 19.76% YoY to RMB1.141 Billion

Stock News
·
Oct 28

HK Pharma Stocks Rose; WUXI XDC And WUXI AppTec Up 7%; HBM Holdings Up 6%; Hengrui Pharma And JW Therap Up 4%

Tiger Newspress
·
Oct 27